Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Related Citations for PubMed (Select 2539203)

1.

Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamine.

Arnold LE, Kleykamp D, Votolato NA, Taylor WA, Kontras SB, Tobin K.

Biol Psychiatry. 1989 Jan 15;25(2):222-8.

PMID:
2539203
2.

Does zinc moderate essential fatty acid and amphetamine treatment of attention-deficit/hyperactivity disorder?

Arnold LE, Pinkham SM, Votolato N.

J Child Adolesc Psychopharmacol. 2000 Summer;10(2):111-7.

PMID:
10933121
3.

Urinary phenethylamine response to d-amphetamine in 12 boys with attention deficit disorder.

Zametkin AJ, Brown GL, Karoum F, Rapoport JL, Langer DH, Chuang LW, Wyatt RJ.

Am J Psychiatry. 1984 Sep;141(9):1055-8.

PMID:
6380319
4.

Levoamphetamine vs dextroamphetamine in minimal brain dysfunction. Replication, time response, and differential effect by diagnostic group and family rating.

Arnold LE, Huestis RD, Smeltzer DJ, Scheib J, Wemmer D, Colner G.

Arch Gen Psychiatry. 1976 Mar;33(3):292-301.

PMID:
769721
5.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
6.

The effects of essential fatty acid supplementation by Efamol in hyperactive children.

Aman MG, Mitchell EA, Turbott SH.

J Abnorm Child Psychol. 1987 Mar;15(1):75-90.

PMID:
3553274
7.

A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder.

Pelham WE, Gnagy EM, Chronis AM, Burrows-MacLean L, Fabiano GA, Onyango AN, Meichenbaum DL, Williams A, Aronoff HR, Steiner RL.

Pediatrics. 1999 Dec;104(6):1300-11.

PMID:
10585981
8.

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group.

Pediatrics. 2004 Mar;113(3 Pt 1):e206-16.

PMID:
14993578
9.

Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings.

Donnelly M, Rapoport JL, Potter WZ, Oliver J, Keysor CS, Murphy DL.

Arch Gen Psychiatry. 1989 Mar;46(3):205-12.

PMID:
2645848
11.
12.

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.

Greenhill LL, Findling RL, Swanson JM; ADHD Study Group.

Pediatrics. 2002 Mar;109(3):E39.

PMID:
11875167
13.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
14.
16.

An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.

Nikles CJ, Mitchell GK, Del Mar CB, Clavarino A, McNairn N.

Pediatrics. 2006 Jun;117(6):2040-6.

17.

A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Biederman J, Melmed RD, Patel A, McBurnett K, Konow J, Lyne A, Scherer N; SPD503 Study Group.

Pediatrics. 2008 Jan;121(1):e73-84. doi: 10.1542/peds.2006-3695.

18.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
19.

A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder.

Arnold LE, Lindsay RL, Conners CK, Wigal SB, Levine AJ, Johnson DE, West SA, Sangal RB, Bohan TP, Zeldis JB.

J Child Adolesc Psychopharmacol. 2004 Winter;14(4):542-54.

PMID:
15662146
20.

Amino acid supplementation as therapy for attention deficit disorder.

Nemzer ED, Arnold LE, Votolato NA, McConnell H.

J Am Acad Child Psychiatry. 1986 Jul;25(4):509-13. No abstract available.

PMID:
3528266
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk